Enzolytics Inc (ENZC)

[falon]

It depends on what the news is.

Long term ENZC technology/patents can sustain it stock price to a much higher level than where it is today.

There is no reason for it to be higher than it is now.

The company is not producing any income.

The company has been at Texas A&M creating shareholder value that has yet to be realized.

Regeneron next generation Covid antibody is very similar to ENZC process.

Even if Enzolytics and Regeneron are not working together, there is a very likely chance that the targeted conserved site Regeneron intends to use has been patented by ENZC so there is a revenue flow in the making.

Again the Regeneron CEO said it all:

Regeneron, which early on in the pandemic developed a monoclonal antibody cocktail to address a treatment paradigm for COVID, is pivoting to what CEO Len Schleifer called “the jackpot antibody.”


What is extremely important and powerful about ENZC process is that it can be used against different diseases/viruses.